SCHEMBL4138925

SCHEMBL4138925

CCCCN(CCCC)C[Si](OC)(OC)OC

nearest known ligand 0.35

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.35
CA12 O43570 2/20 0.32
CA1 P00915 2/20 0.32
CA9 Q16790 2/20 0.32
MAPT P10636 1/20 0.31
ATP4A P20648 2/20 0.31
ATP4B P51164 2/20 0.31
HTT P42858 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16813245 0.86 ATP4A (0.30) ATP4AATP4B
SCHEMBL1852153 0.85
SCHEMBL9791643 0.85 LMNA (0.46) LMNAATP4AATP4B
SCHEMBL16813455 0.84 ALDH1A1 (0.33) HTT
SCHEMBL16813376 0.83
SCHEMBL16813713 0.81 SIGMAR1 (0.33)
SCHEMBL1326185 0.81 LMNA (0.35) LMNA
SCHEMBL25311709 0.80 ALDH1A1 (0.37) LMNAMAPT
SCHEMBL1567057 0.79 LMNA (0.47) LMNACA12CA1CA9MAPT
SCHEMBL3466842 0.79 CA12 (0.31) CA12CA1CA9MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0369443-B1 Positively chargeable developer CANON KK (JP) 1996-04-10 EP claimed
JP-63083166-A None JP disclosed
EP-4590775-A1 CROSS-LINKABLE COMPOSITION AND METHOD FOR PRODUCING COATING LAYER USING THE COMPOSITION Wacker Chemie AG (DE) 2025-07-30 EP disclosed
EP-4541800-A1 NITROGEN-CONTAINING SILANE COMPOUND AND METHOD FOR PRODUCING SAME Shin-Etsu Chemical Co., Ltd. (JP) 2025-04-23 EP disclosed
US-20250122230-A1 NITROGEN-CONTAINING SILANE COMPOUND AND METHOD FOR PRODUCING SAME SHIN-ETSU CHEMICAL CO., LTD. (JP) 2025-04-17 US disclosed
WO-2024179752-A1 CROSS-LINKABLE COMPOSITION AND METHOD FOR PRODUCING COATING LAYER USING THE COMPOSITION WACKER CHEMIE AG (DE) 2024-09-06 WO disclosed
US-11965094-B2 Curable organopolysiloxane compositions WACKER CHEMIE AG (DE) 2024-04-23 US disclosed
EP-4208509-B1 CROSS-LINKABLE COMPOSITIONS BASED ON ORGANOSILICON COMPOUNDS WACKER CHEMIE AG (DE) 2024-02-28 EP disclosed
EP-4157943-B1 CROSS-LINKABLE MASSES BASED ON ORGANOSILICON COMPOUNDS WACKER CHEMIE AG (DE) 2024-01-31 EP disclosed
US-20230399513-A1 MIXTURES CONTAINING PHOSPHORUS COMPOUNDS AND USE THEREOF WACKER CHEMIE AG (DE) 2023-12-14 US disclosed
EP-2789656-A1 Crosslinkable compositions based on organosilicon compounds Wacker Chemie AG (DE) 2014-10-15 EP disclosed
EP-1879956-B1 METHOD FOR PRODUCING CROSSLINKABLE ORGANOPOLYSILOXANE DISPERSIONS WACKER CHEMIE AG (DE) 2013-03-06 EP disclosed
US-20090264612-A1 ALKOXYSILANE-TERMINATED PREPOLYMERS WACKER CHEMIE AG (DE) 2009-10-22 US disclosed
US-20090227792-A1 HIGHLY REACTIVE a-AMINOMETHYL-ALKOXYSILANES HAVING IMPROVED STABILITY WACKER CHEMIE AG (DE) 2009-09-10 US disclosed
EP-1824865-B1 HIGHLY REACTIVE ALPHA-AMINOMETHYL-ALKOXYSILANES HAVING IMPROVED STABILITY WACKER CHEMIE AG (DE) 2009-06-17 EP disclosed
EP-1824904-B1 ALKOXYSILANE-TERMINATED PREPOLYMERS WACKER CHEMIE AG (DE) 2008-11-05 EP disclosed
EP-1824865-A2 HIGHLY REACTIVE ALPHA-AMINOMETHYL-ALKOXYSILANES HAVING IMPROVED STABILITY Wacker Chemie AG (DE) 2007-08-29 EP disclosed
WO-2006061091-A2 HIGHLY REACTIVE $G(A)-AMINOMETHYL-ALKOXYSILANES HAVING IMPROVED STABILITY WACKER CHEMIE AG (DE) 2006-06-15 WO disclosed
EP-0369443-A2 Positively chargeable developer CANON KABUSHIKI KAISHA (JP) 1990-05-23 EP disclosed
JP-S6383166-A ROOM TEMPERATURE-CURABLE ORGANOPOLYSILOXANE COMPOSITION TORAY SILICONE CO LTD 1988-04-13 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250122230-A1 NITROGEN-CONTAINING SILANE COMPOUND AND METHOD FOR PRODUCING SAME HRH3, HRH4, OR10J3 LMNA 4196/4885CA12 903/4885CA1 269/4885
US-20090264612-A1 ALKOXYSILANE-TERMINATED PREPOLYMERS MYB, ACMSD, PLOD1 LMNA 10/4885CA12 1537/4885CA1 1786/4885
US-20090227792-A1 HIGHLY REACTIVE a-AMINOMETHYL-ALKOXYSILANES HAVING IMPROVED STABILITY AAAS, PCNA, AASDHPPT LMNA 145/4885CA12 1584/4885CA1 831/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.